Fiat-valuta's
Cryptovaluta's
Geen resultaten voor ""
We konden niets vinden dat overeenkomt met uw zoekopdracht. Probeer het opnieuw met een andere term.
NewLimit - Series A
Overzicht
Financieringsdatum
May 16, 2023
Financieringsbedrag
$40M
Waardering
--
Categorie
Subcategorie
--
Over NewLimit - Series A
Investeerders
Investeerders | Type | Locatie | Jaar Opgericht | #Portfolio Bedrijven | E-mailadres | Sociale Media |
---|---|---|---|---|---|---|
Fund | United States of America | -- | 1 | -- | ||
Fund | United States of America | 1972 | 15 | plans@kpcb.com | ||
Fund | United States of America | 2005 | 35 | submissions@foundersfund.com | ||
Angel Investor | -- | -- | 2 | -- | ||
Angel Investor | United States of America | -- | 7 | -- |
Oprichters & Team
Brian Armstrong
Greg Johnson
Jacob Kimmel
Bedrijfsprofiel / Project Introductie
NewLimit was founded to cure aging. They are working toward this goal by uncovering sets of transcription factors that can epigenetically reprogram cells. Although its products are designed to treat aging itself, NewLimit also believe these products could treat or prevent many diseases associated with aging, including fibrosis, infectious disease, and neurodegenerative disease.